Sirtris Pharmaceuticals, Inc. 4
4 · Sirtris Pharmaceuticals, Inc. · Filed Jan 24, 2008
Insider Transaction Report
Form 4
Jirousek Michael
Senior VP, Research
Transactions
- Sale
Common Stock
2008-01-22$12.66/sh−182$2,304→ 34,236 total - Sale
Common Stock
2008-01-22$12.71/sh−18$229→ 33,500 total - Sale
Common Stock
2008-01-22$12.57/sh−385$4,839→ 38,220 total - Sale
Common Stock
2008-01-22$12.47/sh−600$7,482→ 42,693 total - Sale
Common Stock
2008-01-22$12.53/sh−318$3,985→ 40,194 total - Sale
Common Stock
2008-01-22$12.58/sh−418$5,258→ 37,802 total - Sale
Common Stock
2008-01-22$12.59/sh−215$2,707→ 37,345 total - Sale
Common Stock
2008-01-22$12.67/sh−100$1,267→ 34,136 total - Sale
Common Stock
2008-01-22$12.50/sh−500$6,250→ 41,794 total - Sale
Common Stock
2008-01-22$12.67/sh−118$1,495→ 34,018 total - Sale
Common Stock
2008-01-22$12.61/sh−400$5,044→ 36,178 total - Sale
Common Stock
2008-01-22$12.48/sh−399$4,980→ 42,294 total - Sale
Common Stock
2008-01-22$12.51/sh−1,082$13,536→ 40,712 total - Sale
Common Stock
2008-01-22$12.56/sh−1,089$13,678→ 38,605 total - Sale
Common Stock
2008-01-22$12.59/sh−242$3,047→ 37,560 total - Sale
Common Stock
2008-01-22$12.60/sh−767$9,664→ 36,578 total - Sale
Common Stock
2008-01-22$12.46/sh−260$3,241→ 43,293 total - Sale
Common Stock
2008-01-22$12.64/sh−740$9,354→ 34,618 total - Sale
Common Stock
2008-01-22$12.52/sh−200$2,504→ 40,512 total - Sale
Common Stock
2008-01-22$12.55/sh−300$3,765→ 39,694 total - Sale
Common Stock
2008-01-22$12.62/sh−420$5,300→ 35,758 total
Footnotes (1)
- [F1]Sale was effected pursuant to a Rule 10b5-1 Trading Plan previously entered into by Reporting Person.